ProteusDigitalHealth

Developer of #DigiMeds #DigitalMedicines. We believe in healthcare, powered by you.

[ProteusDigitalHealth @ProteusDH]

Otsuka America Pharmaceutical, Inc. has purchased the assets of Proteus Digital Health, Inc., including assets and intellectual property for its ingestible and wearable sensor technology. Follow @OtsukaUS directly to stay in-the-know on info as it is released. #DigitalMedicine

[ProteusDigitalHealth @ProteusDH]

Hep C study with 288 participants (68% with household income under 25k, 47% with active alcohol or substance abuse) shows use of #DigiMeds resulted in 95% adherence rate & >99% cured. Excited to see how #ProteusDiscover can help @TennCareRep tackle #HCV. https://t.co/XYoUPue0ur

[California Life Sciences (CLS) @CALifeSciences]

Fantastic news from CLSA member @ProteusDH and their technology.

Medication adherence is always a challenge and this groundbreaking application to #HepatitisC treatment efforts is great to see.

[ProteusDigitalHealth @ProteusDH]

Tennessee healthcare providers now prescribing Proteus’ #digitalmedicines, strengthening @TennCareRep’s #HepatitisC treatment efforts through an innovative, value-based approach. Read more: https://t.co/9B0RqPS505

[CDC Hepatitis @cdchep]

It's May! Be #HepAware2020 and learn the ABCs of viral #hepatitis to find out if you should get tested or vaccinated https://t.co/XuJevmAFLd #hepA #hepB #hepC

[Fight Colorectal Cancer @FightCRC]

Thank you @ProteusDH for giving our research advocates a tour of your facilities today! Great to see the patient voice integrated a long all aspects of the #colorectalcancer continuum! #patientcentricity @LeeJonesMBA @goodcancernews @66Rose

[Reese Garcia @reese_garcia11]

The RATS training at #GI20 has begun! Thank you @ProteusDH for giving us a tour this morning! #colorectalcancer #research @FightCRC

[FirstWord HealthTech @fwhealthtech]

Our fortnightly round-up of #digitalhealth news you need to know is out, featuring $NOVN .@biofourmis $ALM $GOOGL .@ProteusDH .@AtmoBio $LVGO .@XR_Health $LUPIN .@PropellerHealth https://t.co/SWNxvQLKSu

[Leah Zullig, PhD @LeahZullig]

Learning about the potential of a digital medicine program to improve adherence to oral anti cancer therapies. Thanks to Shelley Jazowski for representing our team! @ProteusDH #DigiMeds #DigitalMedicines @SocMedAdherence @duke_pophealth @HaydenBosworth

[Brian Meshkin @meshkin]

Digital Therapeutic Study Proves Value of #mHealth in Medication Adherence using @ProteusDH - great results! https://t.co/5z0R6qIxfM

[ProteusDigitalHealth @ProteusDH]

HCV study shows 93% overall rate of medication adherence, and a 99.5% rate of sustained virologic response with #DigiMeds

[MobiHealthNews @MobiHealthNews]

HCV patients at risk of nonadherence using Proteus' digital pill achieve sustained viral clearance. #InnovatePharma https://t.co/7IQJV6zYXB

[Ben Lakin @benjaminlakin]

Enjoyed interviewing Jeremy Frank, SVP Digital Medicine at @ProteusDH for a @Clin_Info_News story: https://t.co/aZY0DTXkPu. He shared some excellent insights on #sensors and #digitalmedicine. Come learn from Jeremy and other #medtech faculty at the #sensorssummit! @SensorsGlobal

[ProteusDigitalHealth @ProteusDH]

Recent article by @FierceBiotech breaks down TB manuscript in @PLOSMedicine: Digital Medicines “performed better than directly monitoring drug adherence among patients with tuberculosis taking monthslong maintenance therapies.” https://t.co/1FcdwcxnfZ

[ProteusDigitalHealth @ProteusDH]

Evidence shows that @ProteusDH #DigitalMedicines support high, daily medication adherence in #tuberculosis treatment, with 100% of patients requesting to stay on Digital Medicines. Read the manuscript from Sara Browne of @UCSanDiego here: https://t.co/0BAxO7hRsc

[ProteusDigitalHealth @ProteusDH]

Don’t miss @ProteusCEO as a panelist alongside companies @dr_consulta & @Roivant at the @Founders_Forum Health-tech Founders Panel to discuss how #technology can create a new #healthcare ecosystem. Today at 3:45pm #FoundersForum #HealthTech #FFNYC

[CB Insights @CBinsights]

@ProteusCEO @ProteusDH @emmarcourt @businessinsider "One of the challenges in the US #health system is that when you get paid more for doing more, there is nothing going on to constrain costs. @ProteusDH enables more value to be created for less." #FutureHealth

[CB Insights @CBinsights]

@ProteusCEO @ProteusDH @emmarcourt @businessinsider "Cheap drugs that people don't take don't deliver any value." #FutureHealth

[CB Insights @CBinsights]

@ProteusCEO @ProteusDH @emmarcourt @businessinsider "50%+ of patients with hepatitis C and have a prescription will be denied fill by insurance carriers because they're too risky and may not take their medicines. You can either deny fill and have people be infected, or use #tech to ensure that everyone gets a cure." #FutureHealth

[CB Insights @CBinsights]

In our last fireside chat of the morning session, we're joined by Andrew Thompson (@ProteusCEO), CEO, president, and co-founder of @ProteusDH, in conversation with @emmarcourt of @businessinsider. #FutureHealth https://t.co/FWE7fEjZUQ

[CB Insights @CBinsights]

@ProteusCEO @ProteusDH @emmarcourt @businessinsider "@ProteusDH is building a solution that uses behavioral tools—providing medicine, feedback, and tools to form habits and share data with family members and a care team—that can then do a better job in getting the right drug to the right patient at the right time." #FutureHealth